Journal
JOURNAL OF CROHNS & COLITIS
Volume 2, Issue 4, Pages 348-351Publisher
OXFORD UNIV PRESS
DOI: 10.1016/j.crohns.2008.05.011
Keywords
Crohn's disease; Ulcerative colitis; Anti-TNF agents; Infliximab; Adalimumab; Certolizumab; Tachyphylaxis